United Asset Strategies’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $386K | Buy |
184,608
+100
| +0.1% | +$209 | 0.03% | 203 |
|
|
2025
Q1 | $315K | Buy |
184,508
+300
| +0.2% | +$511 | 0.03% | 207 |
|
|
2024
Q4 | $930K | Sell |
184,208
-34,100
| -16% | -$172K | 0.09% | 139 |
|
|
2024
Q3 | $1.19M | Hold |
218,308
| – | – | 0.11% | 131 |
|
|
2024
Q2 | $1.05M | Sell |
218,308
-3,300
| -1% | -$15.8K | 0.1% | 135 |
|
|
2024
Q1 | $689K | Buy |
221,608
+300
| +0.1% | +$933 | 0.07% | 176 |
|
|
2023
Q4 | $629K | Buy |
221,308
+77,500
| +54% | +$220K | 0.07% | 177 |
|
|
2023
Q3 | $421K | Sell |
143,808
-40,152
| -22% | -$118K | 0.05% | 186 |
|
|
2023
Q2 | $526K | Buy |
183,960
+125,000
| +212% | +$358K | 0.07% | 170 |
|
|
2023
Q1 | $182K | Buy |
58,960
+31,500
| +115% | +$97.3K | 0.02% | 214 |
|
|
2022
Q4 | $57.9K | Buy |
27,460
+12,500
| +84% | +$26.4K | 0.01% | 220 |
|
|
2022
Q3 | $49K | Hold |
14,960
| – | – | 0.01% | 201 |
|
|
2022
Q2 | $48K | Hold |
14,960
| – | – | 0.01% | 201 |
|
|
2022
Q1 | $106K | Buy |
14,960
+4,650
| +45% | +$32.9K | 0.01% | 204 |
|
|
2021
Q4 | $75K | Buy |
10,310
+2
| +0% | +$15 | 0.01% | 204 |
|
|
2021
Q3 | $120K | Buy |
+10,308
| New | +$120K | 0.02% | 196 |
|